{{Rsnum
|rsid=680055
|Gene=CYP3A43
|Chromosome=7
|position=99859982
|Orientation=minus
|GMAF=0.1208
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=CYP3A43
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 10.6 | 89.4
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.0 | 100.0
| YRI | 11.6 | 44.9 | 43.5
| ASW | 5.3 | 43.9 | 50.9
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 10.9 | 89.1
| LWK | 35.5 | 47.3 | 17.3
| MEX | 0.0 | 6.9 | 93.1
| MKK | 18.7 | 47.1 | 34.2
| TSI | 2.0 | 14.7 | 83.3
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs680055
|Name_s=CYP3A43: P340A
|Gene_s=CYP3A, CYP3A43
|Feature=Intron, Exon/NonSyn
|Evidence=PubMed ID:18566991
|Annotation=A study in 1,090 Caucasian prostate cancer cases found significant associations involved CYP3A43 P340A genotypes and history of benign prostatic hyperplasia (BPH). These results of the study suggest that androgen metabolism may act in concert with inflammatory phenotypes such as BPH in determining prostate cancer severity.
|Drugs=
|Drug Classes=
|Diseases=Prostatic Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA162181164
}}

{{PharmGKB
|RSID=rs680055
|Name_s=CYP3A43: 1121C>G; *3; P340A
|Gene_s=CYP3A, CYP3A43
|Feature=Intron, Exon/NonSyn
|Evidence=PubMed ID:14695544; PubMed ID:15548719; PubMed ID:15894682
|Annotation=The CYP3A43*3 allele is characterized by the P340A variant in exon 10. A study at 622 inicident prostate cancer cases and 396 controls suggests a role for this variant in prostate cancer etiology. Another study in African Americans and Caucasians suggests also that this SNP contibutes to prostate cancer risk.
|Drugs=
|Drug Classes=
|Diseases=Prostatic Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA161845792
}}

{{GET Evidence
|gene=CYP3A43
|aa_change=Pro340Ala
|aa_change_short=P340A
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs680055
|overall_frequency_n=1477
|overall_frequency_d=10758
|overall_frequency=0.137293
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=1
|n_articles_annotated=1
|in_pharmgkb=Y
|pph2_score=0.925
|nblosum100=2
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}